The fight against the spread of Tuberculosis (TB) has been thrust back into the spotlight following a march by more than 600 Gauteng-based TB activists affiliated with the NPO, Rural Health Advocacy Project. The group has called for better co-ordination and greater political priority if government aims to eradicate TB by the year 2030. The march comes a just days after the Bill & Melinda Gates Medical Research Institute launched Phase 3 of a clinical trial to assess the efficacy of a TB vaccine which could potentially help prevent pulmonary TB in adolescents and adults. Sakina Kamwendo spoke to national principal investigator for the experimental vaccine called M72/AS01E (M72 for short)in South Africa, Dr Lee Fairlie.